mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.03 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.03 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.03 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.03 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.03 |